Pine Labs IPO yielded investors a profit of around 9.5% on listing. Despite weak GMP and subscriptions completing only on the last day, its performance was better. Shares issued at an issue price of Rs 221 listed at Rs 242.
IPO Listing: Pine Labs IPO has given excellent returns to investors upon listing. Despite weak GMP in the grey market, this IPO performed better than expected. Investors received excellent profits on the very first day of listing.
Investors Benefited from Listing Price
Pine Labs' issue price was Rs 221 per share. At the time of listing, it opened at Rs 242 per share. This means investors received a direct gain of approximately 9.50 percent. Its shares listed at the same price on both NSE and BSE. This listing proved to be much better than investors had hoped.
Subscription Completed on the Last Day
Due to weak signals in the grey market, investors were initially hesitant to trust this IPO. For this reason, retail subscription was completed only on the last day, November 11, 2025. Before listing, its GMP was only Rs 5.5 per share, leading to low expectations for significant gains. Despite this, the listing surprised everyone.
Key Information about Pine Labs IPO
The price band for this IPO was set between Rs 210 and Rs 221. A minimum lot size of 67 shares was mandatory for investment. This means investors had to put in Rs 14,807 for one lot. Despite low subscription and weak GMP, this IPO has generated excellent returns for investors.
